Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 293.31M P/E - EPS this Y 4.90% Ern Qtrly Grth -
Income -60.64M Forward P/E -7.39 EPS next Y 45.90% 50D Avg Chg -16.00%
Sales 24.05M PEG - EPS past 5Y - 200D Avg Chg 1.00%
Dividend N/A Price/Book 3.87 EPS next 5Y - 52W High Chg -36.00%
Recommedations 1.70 Quick Ratio 3.48 Shares Outstanding 50.03M 52W Low Chg 123.00%
Insider Own 8.46% ROA -42.02% Shares Float 29.46M Beta 0.13
Inst Own 56.89% ROE -166.89% Shares Shorted/Prior 4.25M/5.23M Price 8.20
Gross Margin 71.15% Profit Margin -252.18% Avg. Volume 451,262 Target Price 19.17
Oper. Margin -179.18% Earnings Date Nov 6 Volume 295,161 Change -1.32%
About scPharmaceuticals Inc.

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. The company's product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity, drug-device combination product candidate consisting of a prefilled syringe containing SCP-111, preloaded into a commercially available, fixed single dose, disposable, two step mechanical autoinjector. It has a collaboration agreement with West Pharmaceutical Services, Inc. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

scPharmaceuticals Inc. News
11/16/24 Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts
11/15/24 scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations
11/14/24 scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
11/13/24 ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates
11/13/24 scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
11/07/24 TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock?
11/06/24 scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
10/15/24 scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024
10/08/24 Liquidia Technologies (LQDA) Surges 11.2%: Is This an Indication of Further Gains?
09/16/24 Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year
09/04/24 scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/20/24 After losing 35% in the past year, scPharmaceuticals Inc. (NASDAQ:SCPH) institutional owners must be relieved by the recent gain
08/16/24 Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect?
08/15/24 Q2 2024 scPharmaceuticals Inc Earnings Call
08/14/24 ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates
08/14/24 scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
08/12/24 scPharmaceuticals Announces Pricing of $50.0 Million Public Offering
08/12/24 scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors
08/12/24 scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure
08/12/24 scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector
SCPH Chatroom

User Image BeefStewart Posted - 1 day ago

$SCPH crazy to buy 200k shares of this despite lowish average volume? @GoldmanSlaps @Me0wth @OldManLogan ??

User Image barbaresqo Posted - 1 day ago

$SCPH wish I’d added more under $3.40, only got 200 there and 400 at $3.16. but happy to see some signs of life here.

User Image GeniusLoci Posted - 4 days ago

$SCPH Stochastic Buy Signal

User Image PLATINUM_TRADES Posted - 4 days ago

$SCPH big bounce here and finally turning around we keeping it with $3.83-$3.99 area next imo🥊🥊

User Image TheProphetOfProfit Posted - 5 days ago

$SCPH Based off the 5 year weekly timeframe, the $3.24-$3.68 level looks to be a solid spot to add here for a long.

User Image BeefStewart Posted - 5 days ago

@2019Vtrader2025 Have your sentiments shifted at all in the past 2 days? Do you think cers will continue lower? Also, have you taken a look at $SCPH ? I'd be curious to hear your thoughts on that one 🤗

User Image Stocksrunner Posted - 6 days ago

Epic comeback story unfolding! Watch these resilient fighters who turned the tide: $NUWE $WKHS $TCBP $KXIN $SCPH all showed incredible strength, bouncing back from their intraday lows to close higher! These phoenix-like recoveries could signal strong institutional support & shifting momentum. Classic bear trap pattern on display!

User Image WolfOf_MyStreet Posted - 6 days ago

$SCPH 3 days are over (3 day rule). Both RSI and stochastics are oversold on the daily and we have a gap to fill at $3.80. Let’s hope the bottom is in and we can head back to $5 for next PDUFA in March. Wish I was buying here instead of in the $4’s where I started my position.

User Image OldManLogan Posted - 6 days ago

$SCPH Hey Beef, SCPH has $91M in cash; $51M in loans that arent due for a number of years and they have a preexisting commitment from Perceptive for another $50M... Meanwhile, quarterly loss should continue to drop each quarter and I think they should be profitable by Q4 2025... The street, according to Factset, thinks they burn $63M before turning profitable in March of 2026... I think they burn more like $50M and are profitable in Nov/Dec 2025... Cheers. COGS will start dropping later in 2025 and R&D should also drop off now...

User Image BeefStewart Posted - 6 days ago

$SCPH Do they have enough to cover debt and operating expenses without a subsequent capital raise? I believe they said they have enough to make it to profitability, but does anyone have a more pessimistic view of their finances? Long term, I am bullish, but things have not gone well over the past 2 years for bulls...

User Image MITornado Posted - 6 days ago

$SCPH if they do 40 million in revenue this year and are not profitable, then a market cap of 160 million is probably the top. Slow and steady burn up for next year, but as many have pointed out, this will take time.

User Image MITornado Posted - 6 days ago

$SCPH when life hands you lemons, make lemonade.

User Image barbaresqo Posted - 6 days ago

$SCPH average is now $4. Company should be profitable in two years. 🤷‍♂️

User Image DorianMD Posted - 6 days ago

$SCPH looks like this thing will touch 3 dollars, maybe even below 🥴

User Image PenkeTrading Posted - 6 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Scpharmaceuticals Inc. Is that bullish or bearish? $SCPH #Scpharmaceuticals #RsiOversold #NASDAQ

User Image WolfOf_MyStreet Posted - 6 days ago

$SCPH well I went in too early. Sitting on a big loss, although long term I think this is still a good buy, I think short term we will see $3.

User Image _www_larval_com_ Posted - 1 week ago

$SCPH just reverted 3% higher to -10% (~2Mv) a few minutes ago, 11/15 options, follow for more volatility.

User Image Me0wth Posted - 1 week ago

$SCPH I’m in, easy money 😺💰

User Image StewBone Posted - 1 week ago

$SCPH starting a position here

User Image BeefStewart Posted - 1 week ago

$SCPH I would like to better understand their financial situation (debt, dilution, etc). It seems like they are making progress, but not as fast as previously anticipated. I would be happier if the stock traded on higher volume, as it seems to lack liquidity. Perhaps that's not a huge problem in the long run, though...

User Image barbaresqo Posted - 1 week ago

$SCPH orbimed was buying it at $4/share. I’m happy to continue adding lower than that.

User Image WolfOf_MyStreet Posted - 1 week ago

$SCPH $25 price target from TD Cowen today. Will average down in the coming days.

User Image BDE_Worldwide Posted - 1 week ago

$SCPH patient capital will be rewarded.. won’t be an overnight success.. well capitalized, not much dilution risk.. with plenty of milestones and catalysts ahead. Slow boil..

User Image Contributor Posted - 1 week ago

$SCPH I’m in.

User Image StockDoctorBio Posted - 1 week ago

$SCPH early launch and growing 160% y/y and 25% q/q. This is only a $200M market cap commercial biotech. Management has been consistent that 2025 will be a big big year for them

User Image Fortfr Posted - 1 week ago

$SCPH I didn’t get a chance to listen today. I guess the CC didn’t sound to good ??

User Image OldManLogan Posted - 1 week ago

$SCPH So, some perspective on how the autoinjector will improve profits: in the current quarter gross margins were about 67%, but the autoinjector is expected drop COGS by 70%... so you actually get your gross margins close to 90%... and management expects the mix for Furoscix to eventually get to 90-95% of their product mix... I actually think they get to profitability by Q4 2025...

User Image OldManLogan Posted - 1 week ago

$SCPH So autoinjector sNDA by January, then CKD approval by March, autoinjector approval July, autoinjector has a dramatically lower COGS, changes to how the copay burden works in 2025 = Big revenue growth in 2025 and lower COGS... this remains a no brainer for me.

User Image TheMyth2020 Posted - 1 week ago

$SCPH Ive come to the conclusion that, investing in bio stocks is a loosing game long term, after getting smoked on APLT today and now here im better taken the rest of my money and buying blue chips SMH

User Image BeefStewart Posted - 1 week ago

$SCPH what does everyone think?

Analyst Ratings
HC Wainwright & Co. Buy Aug 19, 24
HC Wainwright & Co. Buy May 15, 24
HC Wainwright & Co. Buy Mar 14, 24
Craig-Hallum Buy Sep 7, 23
HC Wainwright & Co. Buy Aug 11, 23
HC Wainwright & Co. Buy Aug 2, 23
HC Wainwright & Co. Buy Jul 19, 23
HC Wainwright & Co. Buy Jun 8, 23
Maxim Group Buy May 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ORBIMED ADVISORS LLC 10% Owner 10% Owner Nov 25 Buy 5.25 762,380 4,002,495 5,328,328 11/29/22
5AM Partners IV, LLC 10% Owner 10% Owner Sep 06 Sell 5.14 226,622 1,164,837 503,112 09/08/22
5AM Partners IV, LLC 10% Owner 10% Owner Apr 11 Sell 5 270,000 1,350,000 537,301 04/13/22